Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093353
Status:
COMPLETED
Last Update Posted:
2010-10-15
First Post:
2004-10-06
Brief Title:
N2003-01 Irinotecan Temozolomide and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Sponsor:
Childrens Hospital Los Angeles
Organization:
Childrens Hospital Los Angeles
Organization Data
Organization:
Childrens Hospital Los Angeles
Class:
OTHER
Study ID:
CDR0000373759
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Hospital Los Angeles
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Lars Wagner MD
Old Organization:
Cincinnati Childrens Hospital Medical Center
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |